Vaccines Shakeup Continues In China: NT Pharma Backs Away From GSK
This article was originally published in The Pink Sheet Daily
Executive Summary
NT Pharma is positioning its decision as an effort to concentrate resources on becoming an end-to-end service provider, but the impact of the new 2010 Chinese Pharmacopoeia on vaccines manufactured by multinational companies may also have been a consideration.